期刊文献+

己糖激酶2在肝癌转移中的调控作用 被引量:5

The role of hexokinase 2 in the metastasis of hepatocellular carcinoma cells
原文传递
导出
摘要 目的探讨己糖激酶2(HK2)在肝癌中的表达及其在肝癌转移中的调控作川。方法采用免疫组化法分析73例肝癌及癌旁组织中HK2的表达。小十扰RNA(siRNA)干扰HK2的表达后,采用细胞划痕实验检测肝癌细胞的运动能力,Transwell实验检测肝癌细胞的侵袭能力,实时荧光定量聚合酶链式反应和Westernblot检测肝癌细胞中调控上皮间质转化(EMT)关键分子E-cadherin、ZO-1、N—cadherin和vimentin的表达.分析HK2在肝癌细胞EMT中的调控作用。结果免疫组化结果显示.肝癌及癌旁组织中HK2的表达水平分别为5.39±3.40和2.16±1.55,差异有统计学意义(P〈0.05)。siRNA干扰HK2的表达后,肝癌细胞的相对迁移距离由1.00±0.54下降至0.56±0.09,差异有统计学意义(P〈0.05);细胞侵袭数南(345±42)个下降至(215±34)个,差异有统计学意义(P〈0.05);肝癌上皮细胞标志物E-eadherin和ZO-1的表达上调,而间质细胞标志物N-cadhefin和vimentin的表达下调。结论HK2在肝癌细胞中的表达升高,通过促进细胞EMT过程而促进肝癌转移。 Objective To investigate the regulatory role of HK2 in the metastasis of hepatocellular carcinoma (HCC). Methods The protein expressions of HK2 in 73 HCC tumor tissues and paired adjacent non-tumor tissues were evaluated by using immunohistoehemical analysis. The scratch wound healing assay and Transwell assay had been used to analyze the migration and invasion of HCC cells with HK2 knockdown. Expressions of epithelial-to-mesenchymal transition (EMT)markers, such as E-cadherin, ZO-l, N-cadherin and vimentin,in HCC cells with HK2 knockdown were determined by qRT-PCR and Western blot analysis. Results The expression levels of HK2 in tumor tissues and adjacent non-tumor tissues were 5.39±3.40 and 2.16± 1.55, respectively. The protein expression of HK2 was significantly higher in tumor tissues compared with adjacent non-tumor tissues of HCC (P〈0.05). Knockdown of HK2 in HCC cells decreased the cell motility from 1.00±0.54 to 0.56±0.09 (P〈 0.05 ), andknuckdown of HK2 in HCC cells decreased the number of invaded cells form 345±42 to 215±34 (P〈0.05). The expression of epithelial markers ZO-1 and E-cadherin were up-regulated, while mesenchymal markers vimentin and N-cadherin were down-regulated in HCC ceils when HK2 was knockeddown. Conclusions HK2 is up-regulated in HCC and promotes cell motility by stimulating EMT.
作者 耿西林 龙卫红 海军 张煜 郑伟 张智勇 杜立学 Geng Xilin Long Weihong Hai Jun Zhang Yu Zheng Wei Zhang Zhiyong Du Lixue(Department of Hepatobiliary Surgery, Shanxi Provincial People's Hospital, Xi'an 710068, China)
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2016年第10期739-742,共4页 Chinese Journal of Oncology
关键词 肝肿瘤 己糖激酶 肿瘤转移 上皮间质转化 Liver neoplasms Hexokinase Neoplasm metastasis Epithelial- mesenchymal transition
  • 相关文献

参考文献16

  • 1OmbratoL, MalanchiI. The EMT universe: space between cancer cell dissemination and metastasis initiation[J]. Crit Rev Oncog, 2014, 19(5):349-361. DOI: 10.1615/CritRevOncog.2014011802.
  • 2DavisFM, StewartTA, ThompsonEW, et al. Targeting EMT in cancer: opportunities for pharmacological intervention[J]. Trends Pharmacol Sci, 2014, 35(9):479-488. DOI: 10.1016/j.tips.2014.06.006.
  • 3PatraKC, WangQ, BhaskarPT, et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer[J]. Cancer Cell, 2013, 24(2):213-228. DOI: 10.1016/j.ccr.2013.06.014.
  • 4PengQ, ZhouQ, ZhouJ, et al. Stable RNA interference of hexokinase Ⅱ gene inhibits human colon cancer LoVo cell growth in vitro and in vivo[J]. Cancer Biol Ther, 2008, 7(7):1128-1135.
  • 5FanFT, ShenCS, TaoL, et al. PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation[J]. Asian Pac J Cancer Prev, 2014, 15(5):1961-1970.
  • 6RichterS, RichterJP, MehtaSY, et al. Expression and role in glycolysis of human ADP-dependent glucokinase[J]. Mol Cell Biochem, 2012, 364(1-2):131-145. DOI:10.1007/s11010-011-1212-8.
  • 7KroemerG, PouyssegurJ. Tumor cell metabolism: cancer′s Achilles′ heel[J]. Cancer Cell, 2008, 13(6):472-482. DOI: 10.1016/j.ccr.2008.05.005.
  • 8KoppenolWH, BoundsPL, DangCV. Otto Warburg′s contributions to current concepts of cancer metabolism[J]. Nat Rev Cancer, 2011, 11(5):325-337. DOI: 10.1038/nrc3038.
  • 9FerreiraLM, HebrantA, DumontJE. Metabolic reprogramming of the tumor[J]. Oncogene, 2012, 31(36):3999-4011. DOI: 0.1038/onc.2011.576.
  • 10JangM, KimSS, LeeJ. Cancer cell metabolism: implications for therapeutic targets[J]. Exp Mol Med, 2013, 45:e45. DOI: 10.1038/emm.2013.85.

同被引文献46

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部